Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
53.3M
-
Shares change
-
+5.41M
-
Total reported value, excl. options
-
$487M
-
Value change
-
+$42.8M
-
Put/Call ratio
-
1.26
-
Number of buys
-
61
-
Number of sells
-
-61
-
Price
-
$9.15
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q4 2018
172 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q4 2018.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.3M shares
of 117M outstanding shares and own 45.45% of the company stock.
Largest 10 shareholders include HealthCor Management, L.P. (4.61M shares), BlackRock Inc. (4.13M shares), FEDERATED INVESTORS INC /PA/ (3.66M shares), FRANKLIN RESOURCES INC (3.2M shares), Senvest Management, LLC (3.09M shares), STATE STREET CORP (3.02M shares), Vanguard Group Inc (2.86M shares), EAGLE ASSET MANAGEMENT INC (2.34M shares), D. E. Shaw & Co., Inc. (2.29M shares), and Chicago Capital, LLC (2.14M shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.